Biocon sets price band for clinical services arm Syngene's IPO
MUMBAI (Reuters) - Drugmaker Biocon Ltd has set the price band for an initial public offering (IPO) of its clinical research services arm, Syngene International Ltd, at 240 rupees to 250 rupees a share, it said on Thursday.
Syngene's IPO shall open for subscription on July 27 and close on July 29, Biocon said in a filing to exchanges.
Biocon said in April that it planned to sell 22 million shares and provide an overallotment option. ($1 = 62.9100 rupees)
(Reporting by Zeba Siddiqui and Abhishek Vishnoi; Editing by Sunil Nair)